PCNA and neoplasm: Ki-67 is considered to be a more accurate marker of the proliferative stage of tumour cells than proliferating-cell nuclear antigens (PCNA), and Ki-67 immunoreactivity has been reported to correlate with the prognosis of many cancers [15-20].